Shockwave Medical, Inc. has secured a major milestone in medical devices with a newly patented treatment for calcified lesions. This innovation focuses on U.S. Patent titled Shock wave balloon catheter with multiple shock wave sources. The patent describes a targeted therapy designed to fracture specific calcified arterial blocks that often lead to procedural resistance.

Overcoming Vascular Calcification Hardening

Patent Abstract: An apparatus includes a balloon adapted to be placed adjacent a calcified region of a body. The balloon is inflatable with a liquid. The apparatus further includes a shock wave generator within the balloon that produces shock waves that propagate through the liquid for impinging upon the calcified region adjacent the balloon. The shock wave generator includes a plurality of shock wave sources distributed within the balloon.

Swanson Reed Patent of the Month Recognition

Shockwave Medical, Inc. has achieved a significant milestone in the cardiovascular care sector by securing the Swanson Reed patent of the month for May 2026. This prestigious recognition highlights the groundbreaking lithotripsy delivery system within the Pharmaceuticals, Medical Devices and Healthcare industry. By enabling uniform acoustic force distribution inside an intravascular balloon, this invention provides an elegant answer to the long standing challenge of asymmetrical arterial calcification which frequently causes balloon ruptures or incomplete vascular expansion.

The technical excellence of this patent lies in its multi source geometric configuration. Traditional lithotripsy catheters typically rely on single or centralized energy emitters, which can lead to uneven shock wave propagation and require frequent catheter repositioning by the operating surgeon. This system overcomes that limitation by integrating a plurality of shock wave sources distributed strategically within the liquid filled balloon, ensuring that acoustic energy radiates outward in a balanced pattern to fracture stubborn calcium deposits evenly across the vessel wall.

This invention represents an outstanding advancement because it bridges the gap between high power lithotripsy and delicate endovascular safety profiles. Providing a reliable method for simultaneous multidirectional calcified plaque disruption minimizes procedural time, decreases the risk of vessel dissection, and optimizes clinical outcomes for complex angioplasty procedures. The recognition from Swanson Reed underscores how this advanced mechanical and acoustic integration sets a new benchmark for device efficiency and patient safety within the global medical device landscape.

United States Research and Development Tax Credit Compliance

The technological advancements achieved by Shockwave Medical, Inc. align perfectly with the guidelines established for the federal research and development tax credit in the United States. To qualify for this incentive, a project must satisfy a rigorous four part test defined under Section 41 of the Internal Revenue Code. This lithotripsy catheter technology satisfies each prong through its systemic resolution of engineering and physiological uncertainties.

• Permitted Purpose: The project involves developing a new or improved business component, specifically an advanced shock wave balloon catheter featuring distributed acoustic energy sources to optimize calcified plaque disruption performance.
• Elimination of Uncertainty: The engineering team faced substantial technical uncertainty regarding how to arrange multiple high voltage emitters within a micro scale catheter environment without inducing electrical arcing or premature material fatigue.
• Process of Experimentation: Shockwave Medical researchers engaged in a systematic process of experimentation, evaluating alternative emitter placements, mapping acoustic wave fields, and measuring balloon material elasticity through laboratory simulation trials.
• Technological in Nature: The research and development activities rely fundamentally on core hard sciences and engineering principles, including biomedical engineering, acoustic physics, electrical engineering, and materials science.

Practical Research and Development Tax Credit Applications

In the context of American innovation incentives, specific engineering workflows qualify as research expenditures. The following three scenarios demonstrate how this patent translates into qualified research activities:

1. Optimizing Acoustic Emitter Spatial Arrays: Conducting iterative bench scale testing and computer simulations to determine the exact distance parameters needed between shock wave sources to maximize mechanical force uniformity.
2. Developing Resilient Polymer Balloon Blends: Engineering and testing novel composite polymer formulations capable of withstanding rapid cyclic acoustic pressure expansions without tearing or delaminating during active deployment.
3. Testing High Voltage Micro Electrical Insulation Systems: Prototyping and evaluating specialized internal shielding mechanisms to ensure safe delivery of electrical energy to multiple sources simultaneously while immersed in conductive liquid.